Abstract
Serotonin (5-HT) is one of the regulators of feeding in humans. Drugs acting on the serotoninergic system are used to treat bulimia nervosa and to enhance the effect of hypocaloric diets in overweight subjects. They act rapidly to normalise feeding when used to treat eating-related problems. To explore the role of the 5-HT transporter (serotonin transporter (SERT)) in the short-term action of serotonin selective reuptake inhibitor fluoxetine, rats were i.p. given the drug for five consecutive days. Acute administration of fluoxetine in male and female rats produced a strong reduction in food intake, an effect that held up when daily treatment was maintained for five consecutive days. This reduction translated into a diminution of body weight that was statistically significant in the case of the males. As a reflection of the body weight change in rats killed after the fifth daily drug injection, retroperitoneal fat pad also decreased; a diminution that was statistically significant in the case of male rats. In these conditions, plasma leptin levels of both male and female rats were lower than in untreated animals. While acute fluoxetine administration did not modify SERT gene expression, subchronic drug treatment increased the content of SERT mRNA in the midbrain raphe complex of both rat genders. These findings may contribute to explain the role of SERT in fluoxetine action on binging and as an adjunct to hypocaloric diets.
Similar content being viewed by others
References
Bello NT, Hajnal A (2006) Acute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing rats. Brain Res Bull 70:422–429
Calapai G, Corica F, Corsonello A et al (1999) Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest 104:975–982
Churruca I, Portillo MP, Casis L et al (2008) Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats. Neuropeptides 42:293–299
Currie PJ, Coscina DV, Fletcher PJ (1998) Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine. Brain Res 800:62–68
Dryden S, Brown M, King P, Williams G (1999) Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine. Horm Metab Res 31:363–366
Fernández-Galaz MC, Fernández-Agulló T, Carrascosa JM et al (2010) Leptin accumulation in hypothalamic and dorsal raphe neurons is inversely correlated with brain serotonin content. Brain Res 329:194–202
Gamaro GD, Prediger ME, Lopes J et al (2008) Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacol Biochem Behav 90:312–317
García-García L, Fuentes JA, Manzanares J (1997) Differential 5-HT-mediated regulation of stress-induced activation of proopiomelanocortin (POMC) gene expression in the anterior and intermediate lobe of the pituitary in male rats. Brain Res 772:115–120
Gobbi M, Crespi D, Foddi MC et al (1997) Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356:22–28
Hastings JA, Wiesner G, Lambert G et al (2002) Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul Pept 103(2–3):67–74
Hay PJ, Claudino AM (2011) Clinical psychopharmacology of eating disorders: a research update. Int J Neuropsychopharmacol 25:1–14
Hay-Schmidt A, Helboe L, Larsen PJ (2001) Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat. Neuroendocrinology 73:215–226
Hrdina PD, Vu TB (1993) Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14:324–331
Jarosz PA, Metzger BL (2002) The effect of opioid antagonism on food intake behaviour and body weight in a biobehavioral model of obese binge eating. Biol Res Nurs 3:198–209
Johnson DA, Ingram CD, Grant EJ et al (2009) Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter. Neuropsychopharmacology 34:399–409
Kornstein SG, Sloan DM, Thase ME (2002) Gender-specific differences in depression and treatment response. Psychopharmacol Bull 36:99–112
Lauzurica N, García-García L, Pinto S et al (2010) Changes in NPY and POMC, but not serotonin transporter, following a restricted feeding/repletion protocol in rats. Brain Res 1313:103–112
Le Poul E, Boni C, Hanoun N et al (2000) Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39:110–122
López JF, Chalmers DT, Vázquez DM et al (1994) Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287–290
Mauri MC, Rudelli R, Somaschini E et al (1996) Neurobiological and psychopharmacological basis in the therapy of bulimia and anorexia. Prog Neuropsychopharmacol Biol Psychiatry 20:207–240
Oliva JM, Urigüen L, Pérez-Rial S, Manzanares J (2005) Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain. Neuropharmacology 49:618–626
Oliver G, Wardle J (1999) Perceived effects of stress on food choice. Physiol Behav 66:511–515
Serretti A, Mandelli L (2010) Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71:1259–1272
Spurlock G, Buckland P, O’Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33:433–440
Sysko R, Sha N, Wang Y et al (2010) Early response to antidepressant treatment in bulimia nervosa. Psychol Med 40:999–1005
Vasvani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85–102
Young WS 3rd, Mezey E, Siegel RE (1986) Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 70:198–203
Acknowledgments
This study was supported by grants from Danone-Universidad Complutense de Madrid (Refs. PR248/01-10147 and PR238/00-9449).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lauzurica, N., García-García, L., Fuentes, J.A. et al. Hypophagia and induction of serotonin transporter gene expression in raphe nuclei of male and female rats after short-term fluoxetine treatment. J Physiol Biochem 69, 69–74 (2013). https://doi.org/10.1007/s13105-012-0188-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-012-0188-5